December 31 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] plans to focus on the expansion of its product portfolio after opening a 75-million lev ($51.1 million/38.3 million euro) solid forms facility this summer, the company's chairman and executive director Ognian Donev said.